Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 102

1.

Assembly dynamics of PML nuclear bodies in living cells.

Brand P, Lenser T, Hemmerich P.

PMC Biophys. 2010 Mar 5;3(1):3. doi: 10.1186/1757-5036-3-3.

2.

Dynamics of component exchange at PML nuclear bodies.

Weidtkamp-Peters S, Lenser T, Negorev D, Gerstner N, Hofmann TG, Schwanitz G, Hoischen C, Maul G, Dittrich P, Hemmerich P.

J Cell Sci. 2008 Aug 15;121(Pt 16):2731-43. doi: 10.1242/jcs.031922. Epub 2008 Jul 29.

3.

Contribution of the C-terminal regions of promyelocytic leukemia protein (PML) isoforms II and V to PML nuclear body formation.

Geng Y, Monajembashi S, Shao A, Cui D, He W, Chen Z, Hemmerich P, Tang J.

J Biol Chem. 2012 Aug 31;287(36):30729-42. doi: 10.1074/jbc.M112.374769. Epub 2012 Jul 7.

4.

Entrapment of viral capsids in nuclear PML cages is an intrinsic antiviral host defense against varicella-zoster virus.

Reichelt M, Wang L, Sommer M, Perrino J, Nour AM, Sen N, Baiker A, Zerboni L, Arvin AM.

PLoS Pathog. 2011 Feb 3;7(2):e1001266. doi: 10.1371/journal.ppat.1001266.

5.

Live cell dynamics of promyelocytic leukemia nuclear bodies upon entry into and exit from mitosis.

Chen YC, Kappel C, Beaudouin J, Eils R, Spector DL.

Mol Biol Cell. 2008 Jul;19(7):3147-62. doi: 10.1091/mbc.E08-01-0035. Epub 2008 May 14.

6.

PML and PML nuclear bodies: implications in antiviral defence.

Everett RD, Chelbi-Alix MK.

Biochimie. 2007 Jun-Jul;89(6-7):819-30. Epub 2007 Jan 27. Review.

PMID:
17343971
7.

Promyelocytic leukemia isoform IV confers resistance to encephalomyocarditis virus via the sequestration of 3D polymerase in nuclear bodies.

Maroui MA, Pampin M, Chelbi-Alix MK.

J Virol. 2011 Dec;85(24):13164-73. doi: 10.1128/JVI.05808-11. Epub 2011 Oct 12.

8.

SUMO5, a Novel Poly-SUMO Isoform, Regulates PML Nuclear Bodies.

Liang YC, Lee CC, Yao YL, Lai CC, Schmitz ML, Yang WM.

Sci Rep. 2016 May 23;6:26509. doi: 10.1038/srep26509.

9.

Promyelocytic leukemia nuclear bodies are predetermined processing sites for damaged DNA.

Bøe SO, Haave M, Jul-Larsen A, Grudic A, Bjerkvig R, Lønning PE.

J Cell Sci. 2006 Aug 15;119(Pt 16):3284-95. Epub 2006 Jul 25.

10.

Hepatitis C virus core protein inhibits tumor suppressor protein promyelocytic leukemia function in human hepatoma cells.

Herzer K, Weyer S, Krammer PH, Galle PR, Hofmann TG.

Cancer Res. 2005 Dec 1;65(23):10830-7.

11.

Sp100 isoform-specific regulation of human adenovirus 5 gene expression.

Berscheminski J, Wimmer P, Brun J, Ip WH, Groitl P, Horlacher T, Jaffray E, Hay RT, Dobner T, Schreiner S.

J Virol. 2014 Jun;88(11):6076-92. doi: 10.1128/JVI.00469-14. Epub 2014 Mar 12.

12.

Role of promyelocytic leukemia (PML) sumolation in nuclear body formation, 11S proteasome recruitment, and As2O3-induced PML or PML/retinoic acid receptor alpha degradation.

Lallemand-Breitenbach V, Zhu J, Puvion F, Koken M, Honoré N, Doubeikovsky A, Duprez E, Pandolfi PP, Puvion E, Freemont P, de Thé H.

J Exp Med. 2001 Jun 18;193(12):1361-71.

13.

Structure, dynamics and functions of promyelocytic leukaemia nuclear bodies.

Bernardi R, Pandolfi PP.

Nat Rev Mol Cell Biol. 2007 Dec;8(12):1006-16. Review.

PMID:
17928811
14.

Role and fate of PML nuclear bodies in response to interferon and viral infections.

Regad T, Chelbi-Alix MK.

Oncogene. 2001 Oct 29;20(49):7274-86. Review.

16.

Nuclear bodies and compartments: functional roles and cellular signalling in health and disease.

Zimber A, Nguyen QD, Gespach C.

Cell Signal. 2004 Oct;16(10):1085-104. Review.

PMID:
15240004
17.

PML nuclear bodies as sites of epigenetic regulation.

Torok D, Ching RW, Bazett-Jones DP.

Front Biosci (Landmark Ed). 2009 Jan 1;14:1325-36. Review.

PMID:
19273133
18.

Requirement of PML SUMO interacting motif for RNF4- or arsenic trioxide-induced degradation of nuclear PML isoforms.

Maroui MA, Kheddache-Atmane S, El Asmi F, Dianoux L, Aubry M, Chelbi-Alix MK.

PLoS One. 2012;7(9):e44949. doi: 10.1371/journal.pone.0044949. Epub 2012 Sep 18.

19.

Oxidative stress-induced assembly of PML nuclear bodies controls sumoylation of partner proteins.

Sahin U, Ferhi O, Jeanne M, Benhenda S, Berthier C, Jollivet F, Niwa-Kawakita M, Faklaris O, Setterblad N, de Thé H, Lallemand-Breitenbach V.

J Cell Biol. 2014 Mar 17;204(6):931-45. doi: 10.1083/jcb.201305148.

20.

The mechanisms of PML-nuclear body formation.

Shen TH, Lin HK, Scaglioni PP, Yung TM, Pandolfi PP.

Mol Cell. 2006 Nov 3;24(3):331-9.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk